Trials / Unknown
UnknownNCT03669913
Mitigating Adverse Sexual and Reproductive Health Outcomes Among Young Adolescents
Mitigating Adverse Sexual and Reproductive Health Outcomes Through a Comprehensive Primary School Sexuality Education Program in South-Western Uganda
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,100 (estimated)
- Sponsor
- Mbarara University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 10 Years – 14 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effectiveness of comprehensive sexuality education (CSE) among young adolescents (10-14 years) in schools. A total of 33 schools will participate in the trial with 15 intervention arm that will receive CSE education and 18 in the control arm, Intervention will go on for one year
Detailed description
The International Technical Guidance on Sexuality Education (ITGSE) defines CSE as "an age-appropriate, culturally relevant approach to teaching about sexuality and relationships by providing scientifically accurate, realistic, non-judgmental information and CSE improves sexual and reproductive health outcomes of young people by delaying sexual debut, promoting condom use and increasing sexual health knowledge, however, most of these outcomes have been reported in older adolescents and there is limited evidence for effectiveness of CSE among young adolescents The study aims at improving adolescent sexual and reproductive health of young adolescents through CSE that is led by interdisciplinary university students' team in an environment where no consistent or regulated sexual and reproductive health education program currently exists
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lessons on comprehensive sexuality education | Provision of 11 standardized lessons on comprehensive sexuality education based on international guidance on sexuality education by UNESCO |
Timeline
- Start date
- 2015-11-08
- Primary completion
- 2017-11-30
- Completion
- 2018-12-31
- First posted
- 2018-09-13
- Last updated
- 2018-09-13
Source: ClinicalTrials.gov record NCT03669913. Inclusion in this directory is not an endorsement.